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Abstract
Intracellular transport and degradation of membrane anchored heparan sulfate proteoglycans (HSPGs) were studied in
cultured rat hepatocytes labeled with [35S]sulfate and [3H]glucosamine. Pulse chase experiments showed that membrane
anchored HSPGs were constitutively transported to the cell surface after completion of polymerization and modification of
the glycosaminoglycan chains in the Golgi apparatus. The intact HSPGs had a relatively short residence time at the cell
surface and in non-degrading compartments (T1=2 V2^3 h), while [35S]sulfate labeled degradation products were found in
lysosomes, and to a lesser extent in late endosomes. These degradation products which were free heparan sulfate chains with
little or no protein covalently attached, were approximately half the size of the original glycosaminoglycan chains and were
the only degradation intermediate found in the course of HSPG catabolism in these cells. In cells incubated in the presence of
the microtubule perturbant vinblastine, or in the presence of the vacuolar ATPase inhibitor bafilomycin A1, and in cells
incubated at 19‡C, the endocytosed HSPGs were retained in endosomes and no degradation products were detected.
Disruption of lysosomes with glycyl-phenylalanine 2-naphthylamide (GPN) revealed a GPN resistant degradative
compartment with both intact and partially degraded HSPGs. This compartment probably corresponds to late endosomes.
Treatment of hepatocytes with the thiol protease inhibitor leupeptin inhibited the final degradation of the protein moiety of
the HSPGs. The protein portion seems to be degraded completely before the glycosaminoglycan chains are cleaved. The
degradation of the glycosaminoglycan chains is rapid and complete with one observable intermediate. ß 2001 Published by
Elsevier Science B.V.
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1. Introduction
The cell surface of most mammalian cells contains
membrane anchored heparan sulfate proteoglycans
(HSPGs) which have important functions in cell ad-
hesion processes [1^3], in cell proliferation and as
low a⁄nity co-receptors for various growth factors,
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including hepatocyte growth factor [4], transforming
growth factor L [5] and ¢broblast growth factors [6].
HSPGs have been shown to participate in the inter-
nalization of several ¢broblast growth factors [7^10].
It has also been speculated that HSPGs participate in
growth control by translocating HS oligosaccharides
bound to growth factors to the nucleus after internal-
ization and partial degradation of the HS proteogly-
cans [11].
The metabolic turnover of cell surface HSPGs has
been studied in several cell systems [12^15], but little
is known about the pathways for degradative pro-
cessing of these molecules. The best characterized
intracellular degradation pathway for HSPGs is
that of rat ovarian granulosa cells [16,17]. In these
cells, two kinetically distinct pathways have been
identi¢ed. In the ¢rst pathway, HSPGs with trans-
membrane protein domains were found to undergo
three distinct degradation steps after endocytosis.
The ¢rst two steps occurred in prelysosomal com-
partments. First, the core protein was digested, gen-
erating free HS glycosaminoglycan (GAG) chains
which were partially degraded (T1=2 V30 min).
These fragments remained the same size for approx.
1 h before they were cleaved in a second step. The
cleaved HS fragments remained unmodi¢ed for a rel-
atively long period of time (T1=2 V3 h). The third
degradation step, which occurred in lysosomes, was
rapid and complete without observable intermedi-
ates. In the second pathway, glycosylphosphatidyl-
inositol (GPI) anchored HSPGs were quickly trans-
ported to lysosomes after endocytosis (T1=2 V25
min). As in the ¢rst pathway, lysosomal degradation
was rapid and complete.
The major proteoglycans of the rat hepatocyte
plasma membrane have been identi¢ed as HSPGs
[18,19]. These are mostly found at the sinusoidal do-
main of the plasma membrane, but also in endo-
somes, lysosomes and the Golgi apparatus [20]. In
cultured rat hepatocytes, the half-life of membrane
anchored HSPGs has been estimated to be 5^6 h
[14]. Moreover, a low molecular mass HS fragment
of V7 kDa, formed during catabolism of HSPGs,
has been found associated with lysosomes in these
cells [21]. No attempts so far have been made to
dissect the endocytic pathway in detail by use of
subcellular fractionation to determine the intracellu-
lar sites of HSPG degradation.
In the present study, we have characterized the
intracellular degradation pathway of membrane in-
tercalated HSPGs in cultured rat hepatocytes. Trans-
port of HSPGs was studied by subcellular fractiona-
tion in pulse chase experiments. The degradation
pattern of these molecules was examined by gel chro-
matography analyses of 35S labeled PGs in the frac-
tions. To determine the intracellular locations of the
various degradation steps, we interfered with intra-
cellular tra⁄cking and endosomal and lysosomal
degradation by incubation at reduced temperature
and by treatment with vinblastine, ba¢lomycin A1
and leupeptin.
2. Experimental procedures
2.1. Animals and reagents
Male Wistar rats, weighing 200^250 g, were used
in all experiments. The animals were fed standard
laboratory pellet ad lib. Collagenase (type I), b-ni-
trophenyl-N-acetyl-L-D-glucosamine,dexamethasone,
vinblastine, ba¢lomycin A1, leupeptin, pronase (pro-
tease type XIV), Triton X-100, dextran blue, phen-
ylmethylsulfonyl £uoride (PMSF), antipain, glycyl-
L-phenylalanine 2-naphthylamide (GPN) and pep-
statin A were all obtained from Sigma (St. Louis,
MO, USA). K2CrO4 was obtained from Merck
(Darmstadt, Germany). Nycodenz and Maxidens
were bought from Nycomed (Oslo, Norway). Cell
culture £asks and dishes were purchased from Co-
star (Cambridge, MA, USA). Dulbecco’s modi¢ed
Eagle’s medium (DMEM), penicillin/streptomycin
and L-glutamine were obtained from Bio Whittaker
(Verviers, Belgium). RPMI 1640 medium without
sulfate, fetal calf serum and horse serum were ob-
tained from Gibco BRL (Paisley, UK). Insulin was
obtained from Novo (Copenhagen, Denmark).
Sepharose CL-6B and Sephadex G-50 Fine were
obtained from Pharmacia LKB Biotechnology
(Uppsala, Sweden). BCA protein assay reagent was
purchased from Pierce (Rockford, IL, USA).
[35S]Sulfate, 14C labeled molecular mass standards
and Amplify were obtained from the Radiochemical
Centre (Amersham, UK). Ultima gold AB and Insta
gel II plus were obtained from Packard (Groningen,
The Netherlands).
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2.2. Isolation and culturing of hepatocytes
Isolated hepatocytes were prepared by two-step
collagenase perfusion according to Seglen [22]. The
cells were washed and puri¢ed by low speed centri-
fugation as described [23] and centrifuged through
40% Percoll at 210Ug for 10 min. This is a modi¢-
cation of the Percoll gradient protocol used by
Clarke and Weigel [24]. After another three washes
in sulfate-free or glucose-free medium, the cells were
suspended in the same medium and seeded (V1U105
cells/cm2) in: (a) Costar 75 cm2 cell culture £asks
(cell fractionation experiments) or (b) Costar six-
well clusters (pronase incubation experiments). After
1 h at 37‡C unattached cells were aspirated and fresh
RPMI (6sulfate or glucose) containing 0.4 mCi/ml
of [35S]sulfate or [3H]glucosamine was added. In
pulse chase experiments, a 10 or 30 min incubation
in the presence of [35S]sulfate was followed by two
washes in ice cold PBS before growth medium
(DMEM) with or without 5 mM MgSO4 (¢nal con-
centration) was added. The media used were bicar-
bonate bu¡ered: (a) RPMI 1640 medium without
sulfate or glucose supplemented with 1% glutamine
and 2% fetal calf serum; (b) DMEM supplemented
with 2.5% horse serum, 1% glutamine, penicillin (100
units/ml), streptomycin (0.1 mg/ml), insulin (400 nM)
and dexamethasone (0.25 WM). The cells were cul-
tured in 95% air and 5% CO2 at 37‡C. The viability
of the cells was always greater than 95% (trypan blue
exclusion test).
2.3. Cell fractionation
After a pulse with 400 WCi/ml [35S]sulfate, the cells
were chased for various lengths of time, and then
washed twice in ice cold isotonic sucrose solution
(0.25 M sucrose, 1 mM EDTA, 1 mM HEPES, pH
7.2) supplemented with 5 mM MgSO4 (¢nal concen-
tration). The cells were then removed from the £asks
by means of a rubber policeman and suspended in
5 ml isotonic sucrose solution supplemented with a
mixture of the protease inhibitors leupeptin (1 mg/
ml), PMSF (4 mg/ml), antipain (1 mg/ml) and pep-
statin A (1 mg/ml). The cells were pelleted by centri-
fugation (300UgU5 min), and the pellet was resus-
pended in 150 Wl isotonic sucrose solution.
Homogenization was done by passing the cells 5^15
times through a 1^200 Wl pipet tip followed by 5^10
times through a 25 GU1 needle. A postnuclear
supernatant (PNS) was prepared by centrifugation
for 2 min at 2000Ug. PNS was then layered on
top of linear sucrose gradients (34 ml) with a density
range from 1.03 to 1.25 g/ml and centrifuged in a
Beckman SW-28 rotor at 4‡C at 72 000Ug for 7 h.
Alternatively, PNS was layered at the bottom of lin-
ear Nycodenz gradients (34 ml) with a density vary-
ing from 1.06 to 1.22 g/ml and centrifuged in a Beck-
man SW-28 rotor at 4‡C at 72 000Ug for 16 h.
Following centrifugation, the gradients were divided
into 18U2 ml fractions by upward displacement with
Maxidens. [35S]Sulfate was measured in aliquots of
the fractions (200 Wl) in a scintillation counter (Tri-
carb 1900 TR, Packard) using Insta gel II plus as
scintillation £uid. L-Acetylglucosaminidase (L-AGA)
was assayed according to Barrett [25] and the density
of each fraction was obtained from its refractive in-
dex. In sucrose gradients we used the formula:
d = 130.9532+3.0115U(n31)30.4647U(n31)2 (n =
refractive index). In Nycodenz gradients we used the
formula: d = nU3.4133.555 (n = refractive index).
Cellular protein was determined by BCA protein as-
say reagent. When presenting 35S radioactivity in the
sucrose gradients, we have not included the values
measured in the ¢ve upper fractions. When analyzed
by Sepharose CL-6B gel chromatography, we found
that these fractions contained mostly free [35S]sulfate.
In the plots from Nycodenz gradients, the three gra-
dient fractions of highest density were not included
for the same reason.
2.4. Gel chromatography
Gel chromatography was performed in 1 cmU45
cm columns of Sepharose CL-6B or Superose 6
equilibrated and eluted at 6 ml/h with 0.2 M sodium
acetate, 6 M guanidine HCl, 0.5% Triton X-100, pH
6.5. Markers for the void (V0) and total volumes (Vt)
were dextran blue and K2CrO4 respectively. The
fractions (1 ml) were measured in a scintillation
counter using Ultima gold AB as scintillation liquid.
2.5. Alkali and HNO2 treatment
PNS fractions from cells pulsed for 10 min with
[35S]sulfate or [3H]glucosamine and chased for 2 h
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and 6 h were prepared as described above. These
postnuclear supernatants were in some experiments
(Fig. 3) applied to DEAE-Sephacel columns to sep-
arate PGs from other labeled molecules. Washes with
0.15 M NaCl and 0.35 M NaCl, both in 0.05 M Tris
bu¡er, pH 7.4 preceded elution with 2 M NaCl. The
latter eluate was then treated with NaOH or HNO2.
Conditions for alkali treatment of PGs were as fol-
lows: [35S]sulfate labeled or [3H]glucosamine labeled
PGs were incubated in 0.5 M NaOH (¢nal concen-
tration) at room temperature overnight. The samples
were neutralized with 5 M HCl prior to analysis by
Sepharose CL-6B or Superose 6 chromatography.
The amount of heparan sulfate was also determined
by Sepharose CL-6B or Superose 6 chromatography,
following nitrous acid treatment at pH 1.5, as de-
scribed by Shively and Conrad [26].
2.6. Sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE)
Monolayer cultures of rat hepatocytes were pulsed
with [35S]sulfate for 10 min and chased for 15 min
before they were solubilized in 4 M guanidine HCl/
2% Triton X-100/0.2 M sodium acetate bu¡er, pH
6.5. Free [35S]sulfate was removed by applying 1 ml
of each fraction to a 4 ml column of Sephadex G-50
Fine in 0.05 M Tris^HCl, pH 8.0/0.15 M NaCl. The
¢rst 1 ml eluting after application was discarded; the
next 1.5 ml was collected and the [35S]sulfate labeled
PGs were subjected to SDS^PAGE. The samples
were boiled in sample bu¡er with 1% SDS and ap-
plied to precast 4^20% gradient gels from Novex
(Encinitas, CA, USA). Standards used were 14C la-
beled rainbow standards from Amersham. After elec-
trophoresis the gels were ¢xed, treated with Amplify
(Amersham), dried and subjected to autoradiography
using Fuji Medical X-ray ¢lm (Fuji, Japan).
2.7. Inhibitor treatment
After 10 min pulse with [35S]sulfate and 15 min
chase at 37‡C cells were incubated at 19‡C (3 h),
or in the presence of vinblastine (2 h), ba¢lomycin
A1 (3 h) or leupeptin (3 h). Growth medium
(DMEM) supplemented with 10 mM HEPES and
5 mM MgSO4 (¢nal concentration) was used during
the chase period at 19‡C. Vinblastine was used at a
¢nal concentration of 50 WM, ba¢lomycin A1 at 1 WM
and leupeptin at 0.25 mM. After the incubation, the
cells were homogenized and fractionated by sucrose
gradient centrifugation, as described above, or they
were incubated in 0.3% pronase (a mixture of exoge-
nously added proteases) in the phosphate free wash
bu¡er described by Seglen [22] at 4‡C for 60 min,
before protease inhibitors were added (the same mix-
ture of protease inhibitors as described above). Pro-
nase incubated cells were then washed three times in
phosphate free wash bu¡er, before they were solubi-
lized in 4 M guanidine HCl/2% Triton X-100/0.2 M
sodium acetate bu¡er, pH 6.5. After pronase wash-
ing, the cells were no longer attached to the plastic.
The following washes were therefore done by centri-
fugation at 4‡C at 210Ug for 2 min after free
[35S]sulfate was removed as described above, 1.5 ml
samples were collected and an aliquot of this was
counted for radioactivity in the scintillation counter.
2.8. Disruption of lysosomes by treatment with GPN
GPN treatment was done as described by Berg et
al. [27]. Brie£y, GPN was freshly dissolved in Me2SO
at a concentration of 100 mM and diluted 100-fold
with isotonic sucrose bu¡ered with 1 mM HEPES,
pH 7.2. Three milliliters PNS were mixed with 1.5 ml
GPN/sucrose, incubated for 10 min at 37‡C, to dis-
rupt lysosomes, before fractionation on linear su-
crose gradients as described.
3. Results
3.1. Fractionation of [35S]sulfate labeled rat
hepatocytes by isopycnic centrifugation in
sucrose gradients followed by gel
chromatography analyses of gradient fractions
In order to follow synthesis, transport and degra-
dation of HSPGs, we ¢rst performed a series of pulse
chase experiments combined with subcellular frac-
tionation. Cultured hepatocytes were labeled for 10
min with inorganic [35S]sulfate. Virtually all the 35S
label incorporated in macromolecules was recovered
in proteoglycans (see below). The cells were then
washed and incubated in chase medium containing
MgSO4 for various lengths of time, before homoge-
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nization and fractionation by isopycnic centrifuga-
tion in sucrose gradients. After the 10 min labeling
period, no distinct peaks appeared in the dense re-
gion of the gradient (Fig. 1a). However, a large
amount of radioactivity was found in the upper frac-
tions of the gradient mostly re£ecting free sulfate as
well as some intact HSPGs in exocytic vesicles of
very low density. After a subsequent 15 min chase
time, the bulk of macromolecular [35S]sulfate was
found in organelles banding at V1.15^1.16 g/ml,
giving rise to a single peak in the density distribution
curve (Fig. 1a). The PGs constituting this peak were
probably at the plasma membrane as they were ac-
cessible to pronase. These results suggest that trans-
port of PGs from the Golgi apparatus to the plasma
membrane takes 10^15 min. It should be noted that
not only the plasma membrane is banding in this
part of the density gradient, but also early and late
endosomes since the early and late endocytic markers
EEA1, rab5 and rab7 banded at this density in the
gradients (not shown). After 2 h of chase, the bulk of
macromolecular [35S]sulfate appeared in organelles
banding at V1.20 g/ml in the gradient (Fig. 1b).
This peak coincides with that of the lysosomal en-
zyme L-AGA (not shown, but see Fig. 7a). The plas-
ma membrane/endosomal peak was now reduced to
a shoulder. After 6 h of chase, this shoulder had
disappeared almost completely and the macromolec-
ular [35S]sulfate was mainly in the lysosomal fraction
(Fig. 1b). By comparing the amount of PGs in the
fractions banding in the plasma membrane/endoso-
mal area after 2 h and 6 h, we estimated the half-life
of HSPGs in these locations to be V2^3 h.
Labeled PGs were analyzed by Sepharose CL-6B
Fig. 1. Fractionation of [35S]sulfate labeled rat hepatocytes by
isopycnic centrifugation in sucrose gradients. Monolayer cul-
tures of rat hepatocytes were pulsed with [35S]sulfate for 10 min
and chased for 0 (b) and 15 (a) min (a), and 2 (R) and 6 (O)
h (b). After the chase period, the cells were homogenized and
fractionated by sucrose gradient centrifugation. [35S]Sulfate was
determined in the fractions, and presented as cpm/mg total pro-
tein measured in the PNS loaded on the gradients. The ¢ve
upper gradient fractions were not included in the gradient pro-
¢les. Panels a and b represent two separate experiments.
Fig. 2. Sepharose CL-6B gel chromatography and SDS^PAGE
analyses of 35S labeled rat hepatocytes. Fractions from density
gradients presented in Figure 1 were analyzed by Sepharose
CL-6B gel chromatography. (a) The V1.15 g/ml gradient frac-
tion in cells chased for 15 min (b), and the V1.16 g/ml gra-
dient fraction in cells chased for 2 h (a). (b) The V1.20 g/ml
gradient fractions in cells chased for 2 h (R), and in cells
chased for 6 h (O). (Insert in a) SDS^PAGE analysis of mono-
layer culture of rat hepatocytes pulsed with [35S]sulfate for 10
min, chased for 15 min and solubilized in 4 M guanidine HCl/
2% Triton X-100/0.2 M sodium acetate bu¡er, pH 6.5. Free
[35S]sulfate was removed, and labeled proteoglycans were sub-
jected to SDS^PAGE.
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gel chromatography. PGs obtained after 15 min
chase eluted in one main peak with Kav V0.40
(Fig. 2a). This material probably corresponds to
the major HSPGs in rat liver plasma membranes
described earlier [18,28]. This notion was supported
by the ¢nding that SDS^PAGE analysis gave one
predominant typical broad PG band (insert in Fig.
2a). Relative to the protein standards these PGs mi-
grated as proteins with a size of V70^150 kDa.
Treatment with NaOH and HNO2 indicated that
these labeled macromolecules consisted of HSPGs
(see below and Fig. 3). The PGs in the lysosomal
fractions eluted in one main peak with Kav V0.70
(Fig. 2b) when analyzed by Sepharose CL-6B gel
chromatography. This corresponds to a low molec-
ular weight component found in rat hepatocytes by
Kjelle¤n et al. [21]. The relative Mr of this component
was V7000 by comparison with the published mo-
lecular weight analysis of Wasteson [29]. The materi-
al was resistant to NaOH treatment, but was de-
graded by HNO2 (described below), indicating that
it is an oligosaccharide of the HS type containing
little or no protein. The size of the full length HS
chains in these PGs has been determined to be 14
[28]^25 kDa [30], thus, the low molecular weight
component in the lysosomal fractions may represent
cleaved and/or partially degraded remnants of full
length HS chains.
These results suggest that membrane anchored
PGs follow an endocytic pathway after transport
from the Golgi apparatus to the plasma membrane.
These PGs seem to be degraded in lysosomal com-
partments, where a population of partially degraded
HS chains is found. When analyzed by Sepharose
CL-6B gel chromatography, some PGs in the gra-
dient fractions banding at 1.16 g/ml also eluted in
the small molecular weight peak at Kav V0.70
(Fig. 2a). This peak was not seen after 15 min of
chase, but it emerged clearly after 2 h of chase, in-
creasing in size up to 3 h of chase (illustrated by the
control in Fig. 5b). It is therefore likely that prely-
sosomal degradation of HSPGs takes place in a com-
partment banding at 1.16 g/ml in the density gra-
dients.
In the presentation of 35S radioactivity distribution
in the sucrose gradients, we have not included the
Fig. 3. Characterization of 35S labeled macromolecules. PNS from cells pulsed for 10 min with [35S]sulfate or [3H]glucosamine and
chased for 2 or 6 h were prepared, and analyzed by Superose 6 (b) This PNS was also treated with NaOH (a) and HNO2 (R) prior
to gel chromatography.
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values measured in the ¢ve upper fractions. We an-
alyzed these fractions by Sepharose CL-6B gel chro-
matography, and found that they contained mostly
free sulfate (not shown). In cells pulsed for 10 min
and chased for 15 min, some intact HSPGs appeared
in these fractions, but constituted less than 5% of the
total 35S labeled macromolecules in the gradient.
These PGs may be localized to the low density or-
ganelle found in Nycodenz gradients (see Fig. 4a).
Also in cells incubated at 19‡C, or in the presence
of vinblastine or leupeptin, some intact HSPGs were
found in the upper ¢ve fractions. This material also
constituted less than 5% of the total 35S labeled mac-
romolecules found in the gradient, and is not in-
cluded in the results presented.
3.2. Characterization of 35S and 3H labeled
macromolecules
Postnuclear supernatants from cells pulse labeled
for 10 min with either [35S]sulfate or [3H]glucosamine
and chased for 2 or 6 h were analyzed by Superose 6
gel ¢ltration (slightly di¡erent Kav values from
Sepharose CL-6B). When treated with NaOH,
GAG chains in proteoglycans are released in full
length from their core proteins by a L-elimination
reaction. As shown in Fig. 3, intact PGs eluted
from the column with a Kav of 0.2^0.4, both after
2 and 6 h chase. A peak with Kav 0.8 (clearly seen
after 6 h chase) was insensitive to alkali treatment,
indicating that this peak contains free GAG chains.
Alkali treatment also produced a new peak of inter-
mediate Kav (0.6), which resembles longer GAGs re-
leased from protein cores. This peak was not seen in
untreated cells, which indicates that GAG chains are
cleaved rapidly after release from the protein core.
The peak of Kav 0.6 was more pronounced in the
[3H]glucosamine labeled samples, indicating that the
GAG chains to some extent may have been subjects
to the action of sulfatases.
To de¢ne the nature of the GAG chains, the sam-
ples were treated with HNO2. This deamination pro-
cedure leads to cleavage of the glycosidic bond be-
tween glucuronic acid and N-sulfated glucosamine
units while N-acetylated amino sugar residues do
not react. The degradation will therefore be speci¢c
for GAGs of the HS/heparin type since other GAG
types are not N-sulfated. As shown in Fig. 3,
[35S]sulfate labeled PGs were completely depolymer-
ized by HNO2 treatment, and are therefore classi¢ed
as HSPGs and HS GAG chains.
Fig. 4. Fractionation of [35S]sulfate labeled rat hepatocytes by
isopycnic centrifugation in Nycodenz gradients and gel chroma-
tography analyses of gradient fractions. (a) Monolayer cultures
of rat hepatocytes were pulsed with [35S]sulfate for 10 min and
chased for 0 (b) and 15 (a) min. Some cells were pulsed with
[35S]sulfate for 30 min and chased for 2 h (F). After the chase
period, the cells were homogenized and fractionated by Nyco-
denz gradient centrifugation. [35S]Sulfate was determined in the
fractions, and presented as cpm/mg total protein measured in
the PNS loaded at the bottom of the gradients. The three gra-
dient fractions of highest density were not included in the ¢g-
ure. (b) The top fraction from the density gradients (V1.08
g/ml in the gradient plot) in cells pulsed for 10 min and chased
for 0 min (R), and in cells pulsed for 10 min and chased for
15 min (O) were analyzed by Sepharose CL-6B gel chromatog-
raphy.
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3.3. Fractionation of [35S]sulfate labeled rat
hepatocytes by isopycnic centrifugation in
Nycodenz gradients followed by gel
chromatography analysis of gradient fractions
To separate the early organelles in the HS proteo-
glycan pathway from the later endocytic organelles
and the plasma membrane, the cells were fractionat-
ed by use of Nycodenz gradients. Cultured cells were
labeled with [35S]sulfate for 10 min and chased for
0 or 15 min. In addition some cells were given a 30
min pulse with [35S]sulfate followed by a 2 h chase.
The cells were then homogenized, and a PNS was
layered at the bottom of Nycodenz gradients. The
gradients were subsequently centrifuged for 16 h
(Fig. 4a). After 10 min pulse only, a signi¢cant
amount of 35S labeled macromolecules were found
in the upper fractions. The amount of radioactivity
in this part of the gradient decreased during the ¢rst
15 min of the chase, and was almost absent after 2 h
of chase. The three gradient fractions of highest den-
sity were not included in the results presented, as CL-
6B gel chromatography analyses showed that they
contained only free [35S]sulfate (not shown).
The top fractions in these gradients were analyzed
by Sepharose CL-6B gel chromatography. The pro-
teoglycans eluted in one main peak with Kav V0.40
(Fig. 4b), corresponding to intact HS proteoglycans.
The density and the gradual disappearance of the 35S
labeled proteoglycans from these organelles after
short chase periods, as well as the size of the proteo-
glycans, suggest that they are bona ¢de secretory
vesicles.
3.4. Intracellular transport and degradation of
[35S]sulfate labeled proteoglycans at
reduced temperature
Transport from early endosomes to late endo-
somes is reduced in cells incubated at 20‡C or less
[31]. In order to determine the extent of degradation
of proteoglycans in early endosomes, cultured hepa-
tocytes were labeled for 10 min with inorganic
[35S]sulfate. The cells were then washed and incu-
bated for 3 h at 19‡C or 37‡C, and subsequently
subjected to subcellular fractionation by sucrose gra-
dient centrifugation. The results showed that in cells
incubated at 19‡C 35S labeled macromolecules accu-
mulated in organelles banding at V1.16 g/ml in the
density gradient. In addition, some labeled material
accumulated at V1.11^1.14 g/ml. In control cells
most 35S labeled macromolecules accumulated in or-
ganelles banding at V1.20 g/ml (Fig. 5a).
Gradient fractions containing [35S]sulfate labeled
material were analyzed by Sepharose CL-6B gel
chromatography. In cells chased both at 19‡C and
37‡C, the proteoglycans eluted in a main peak at a
Kav V0.40 (Fig. 5b). In cells chased at 37‡C some
HS oligosaccharides also eluted in a small molecular
weight peak at Kav V0.70. This peak could not be
detected in cells chased at 19‡C.
These results show that the degradation of HS
proteoglycans is dramatically reduced at 19‡C, prob-
ably due to inhibition of transport to late endosomes
and lysosomes. Instead they reside in an early endo-
somal, non-degrading compartment.
3.5. Intracellular transport and degradation of
[35S]sulfate labeled proteoglycans in the presence
of the microtubule inhibitor vinblastine
Transport from early to late endosomes in hepa-
tocytes is a microtubule dependent process and can
be blocked by using microtubule inhibitors such as
vinblastine [32]. The cells were pulsed for 10 min
with inorganic [35S]sulfate, and chased for 15 min,
as described above. Vinblastine was then added to
the cells at a ¢nal concentration of 50 WM, and the
chase was continued for 2 h before subcellular frac-
tionation by sucrose gradient centrifugation. 35S la-
beled macromolecules from vinblastine treated cells
accumulated mainly in organelles banding at V1.16
g/ml in the density gradient, whereas 35S labeled
macromolecules accumulated to a large extent in or-
ganelles banding at V1.20 g/ml (Fig. 5c).
Gradient fractions containing [35S]sulfate labeled
material were analyzed by Sepharose CL-6B gel chro-
matography. Both in control cells and in vinblastine
treated cells, the proteoglycans eluted in a main peak
at Kav V0.40 (Fig. 5d). The additional small molec-
ular weight peak with Kav V0.70 found for control
cells was not detected in vinblastine treated cells.
These results are compatible with the results ob-
tained with reduced temperature. In vinblastine
treated cells, the proteoglycans are trapped in an
early, non-degrading, endosomal compartment.
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3.6. Intracellular transport and degradation of
[35S]sulfate labeled proteoglycans in the presence
of the vacuolar ATPase inhibitor ba¢lomycin A1
To examine the relationship between degradation
and intracellular transport of [35S]sulfate labeled pro-
teoglycans, the cells were treated with ba¢lomycin
A1. In cells treated with this vacuolar ATPase inhib-
itor the pH will rise in the vacuolar system, inhibiting
the activity of acid proteases. Cells were pulsed for
10 min with inorganic [35S]sulfate, and chased for 15
min, as described above. Ba¢lomycin A1 was then
added to the cells to a ¢nal concentration of 1 WM,
and the chase was continued for another 3 h before
subcellular fractionation by sucrose gradient centri-
fugation. The results obtained showed that 35S la-
beled macromolecules accumulated in organelles
banding at V1.16 g/ml in ba¢lomycin A1 treated
Fig. 5. Intracellular transport and degradation of 35S labeled proteoglycans in the presence of perturbants of intracellular transport.
Monolayer cultures of rat hepatocytes were pulsed with [35S]sulfate for 10 min and chased for 15 min. The chase was then continued
for 3 h (cells incubated in the presence of vinblastine were only chased for 2 h) at 19‡C (a) or at 37‡C (b) (a), in the presence (a) or
absence (b) of vinblastine (c), ba¢lomycin A1 (e), or leupeptin (g). After the chase period, the cells were homogenized and fractionat-
ed by sucrose gradient centrifugation. [35S]Sulfate was determined in the fractions, and presented as cpm/mg total protein measured in
the postnuclear supernatant loaded on the gradients. The ¢ve upper gradient fractions were not included in the ¢gure. The V1.16
g/ml fractions from the density gradients of the cells chased at 19‡C (O) or at 37‡C (R) (b), in the presence (O) or absence (R) of
vinblastine (d), or ba¢lomycin A1 (f), were analyzed by Sepharose CL-6B gel chromatography. From the density gradients of cells
chased with (O) or without (R) leupeptin (h), the V1.21 g/ml fractions were analyzed. An aliquot of the latter gradient fraction was
also treated with NaOH prior to the Sepharose CL-6B gel chromatography (9).
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cells. In control cells 35S labeled macromolecules ac-
cumulated in organelles banding at V1.20 g/ml (Fig.
5e).
Gradient fractions containing [35S]sulfate labeled
material were analyzed by Sepharose CL-6B gel
chromatography. Both in control cells and in ba¢-
lomycin treated cells, the proteoglycans eluted in a
main peak at a Kav V0.40 (Fig. 5f). The small
molecular weight peak with Kav V0.70 seen in con-
trol cells was absent in the ba¢lomycin A1 treated
cells.
3.7. Degradation pattern of [35S]sulfate labeled
proteoglycans in the presence of the protease
inhibitor leupeptin
To examine the degradation process of proteogly-
cans in lysosomes, the thiol protease inhibitor leu-
peptin was used. The cells were pulsed for 10 min
with inorganic [35S]sulfate and chased for 15 min, as
described above. Leupeptin was then added to the
cells to a ¢nal concentration of 0.25 mM, and the
chase was continued for 3 h before subcellular frac-
tionation by sucrose gradient centrifugation. The re-
sults showed that the amount of 35S labeled macro-
molecules accumulating in the lysosomal area
increased about 45% when leupeptin was present
(Fig. 5g).
Gradient fractions containing [35S]sulfate labeled
material were analyzed by Sepharose CL-6B gel
chromatography. In leupeptin treated cells, the
main peak was slightly shifted and the proteoglycans
eluted at a Kav V0.60 (Fig. 5h). Moreover, this peak
was quite broad in appearance, giving rise to an in-
crease of about 45% of intermediate sized proteogly-
can remnants (Kav V0.40^0.70). The appearance of
these intermediate sized degradation products in leu-
peptin treated cells may be remnants not seen in un-
treated cells due to rapid degradation. To investigate
the nature of these intermediate sized degradation
products, a gradient fraction from the lysosomal
area of gradients from leupeptin treated cells was
further treated with NaOH (Fig. 5h). This treatment
resulted in a slight but reproducible shift in elution
position, indicating that peptide stubs of various
sizes are attached to the oligosaccharide chains
present in this lysosomal compartment in leupeptin
treated cells.
3.8. Internalization of proteoglycans in cells exposed
to vinblastine, ba¢lomycin A1 or low temperature
The density distribution of plasma membrane and
endosomes in sucrose gradients coincides. It was
therefore possible that some of the e¡ects seen by
treatment with vinblastine, ba¢lomycin A1 or re-
duced temperature was due to reduced internaliza-
tion rather than inhibition of intracellular transport
of HS proteoglycans. An assay was therefore set up
to investigate whether the proteoglycans were re-
tained at the plasma membrane in the presence of
the inhibitors. The cells were pulsed for 10 min
with inorganic [35S]sulfate and chased for 15 min
before the di¡erent inhibitors were added and the
chase continued, as described above. At the end of
the chase period, the cells were incubated with pro-
nase at 4‡C for 60 min to digest proteoglycans still
residing at the plasma membrane. Finally, the cells
were lysed in guanidine, and free [35S]sulfate was
removed by gel chromatography. The results shown
in Fig. 6 indicate that V47% of the labeled proteo-
glycans were associated with pronase-inaccessible
compartments after 10 min pulse and 15 min chase.
This proportion includes labeled proteoglycans that
Fig. 6. Internalization of proteoglycans in cells exposed to vin-
blastine, ba¢lomycin A1 or low temperature. Monolayer cul-
tures of rat hepatocytes were pulsed with [35S]sulfate for 10 min
and chased for 15 min. The chase was then continued for 0 min,
2 h and 3 h at 37‡C without the presence of inhibitors, and for
2 h in the presence of vinblastine or for 3 h at 19‡C or in the
presence of ba¢lomycin A1. The cells were then incubated for
60 min at 4‡C in a bu¡er with (E) or without (l) pronase, fol-
lowed by washing and solubilizing in guanidine, before the free
[35S]sulfate was removed. Each point represents the mean+S.D.
of three di¡erent experiments.
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were transported to the cell surface, followed by in-
ternalization and subsequent sorting either to the
recycling pathway or to the degrading pathway, be-
fore the pronase incubation. After 2 h V60% of the
proteoglycans were pronase-inaccessible in the con-
trol cells, while V50% were pronase-inaccessible in
vinblastine treated cells. In cells treated for 3 h, the
proportions of pronase-inaccessible proteoglycans
were 52%, 46% and 45% for respectively control
cells, ba¢lomycin A1 treated cells and cells chased
at 19‡C. This shows that the internalization process
is only partly inhibited by vinblastine, low temper-
ature and ba¢lomycin A1 treatment. Furthermore,
proteoglycans accumulate above control values in
the inhibitor treated cells. We therefore conclude
that this accumulation is to a great extent occurring
in intracellular compartments.
By comparing the amount of HS proteoglycans in
the cells after 10 min pulse and 15 min, 2 h and 3 h
chase, a metabolic turnover rate can be estimated to
T1=2 V2^3 h.
3.9. GPN release of [35S]sulfate from lysosomes
A common problem in subcellular fractionation is
to determine whether markers which co-localize in
the density gradient reside within the same organelle,
or merely in di¡erent sets of organelles whose density
distribution coincide. There are several ways to cir-
cumvent this limitation. One widely used approach is
to shift the density of a given organelle, to see
whether this also in£uences the density distribution
of the marker(s) of interest. A more radical approach
is to disrupt the organelles of interest by a biochem-
ical treatment that causes osmotic lysis.
To decide whether the HS proteoglycan fragments
were formed in the lysosomes we disrupted the lyso-
somes in hepatocytes by GPN to see if this treatment
would in£uence the density distribution of the HS
proteoglycans in sucrose gradients. Treatment with
GPN has been shown to cause rupture of lysosomes
while leaving other endocytic organelles intact [27].
GPN di¡uses into lysosomes where it is hydrolyzed
by cathepsin C [33] to free amino acids, which due to
their polarity do not readily di¡use back, but instead
accumulate inside the lysosome and cause osmotic
lysis of the organelle.
Cultured hepatocytes were labeled for 10 min with
inorganic [35S]sulfate, washed and chased in medium
containing unlabeled sulfate for 180 min. After ho-
mogenization the PNS was divided into two portions
and incubated with or without GPN/sucrose and
fractionated by sucrose gradient centrifugation.
Treatment with GPN led to disruption of a large
fraction of the lysosomes (Fig. 7a). The density dis-
tribution of the lysosomal enzyme L-AGA was
Fig. 7. E¡ect of GPN on release of 35S labeled proteoglycans
from lysosomes. (a) Monolayer cultures of rat hepatocytes were
pulsed with [35S]sulfate for 10 min and chased for 180 min at
37‡C. After homogenization, the postnuclear supernatant was
divided into two portions, incubated for 10 min at 37‡C in the
presence (a) or absence (b) of 0.5 mM GPN and fractionated
by sucrose gradient centrifugation. L-Acetylglucosaminidase was
measured in the fractions and presented as % of total enzyme
activity in the gradients. (b) [35S]Sulfate was determined in the
fractions, and presented as % of total radioactivity in the gra-
dients. (c) The V1.17 g/ml fractions from the density gradients
of the GPN treated postnuclear supernatant (a), and the
V1.16 g/ml fractions from the control gradient (b), were ana-
lyzed by Sepharose CL-6B gel chromatography.
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shifted from the lysosomal area (V1.20 g/ml) to-
wards the low density fractions (V1.05^1.10 g/ml)
of the gradient. The e¡ect of GPN was restricted
to lysosomes since a smaller peak at V1.17 g/ml,
presumably representing late endosomes, was less af-
fected. The disruption of lysosomes by GPN treat-
ment had pronounced e¡ects on the density distribu-
tion of HS degradation products in the gradient (Fig.
7b). 35S radioactivity in the lysosomal area was al-
most completely absent, clearly showing that HS
degradation was indeed taking place in lysosomes.
A fraction of the radioactivity, however, was not
shifted to the top of the gradient but was instead
found at V1.17 g/ml. This probably represents
non-disrupted lysosomes which had been swollen
by the GPN treatment and therefore had become
less buoyant. Gradient fractions from this area
(V1.16^1.17 g/ml) were analyzed by Sepharose CL-
6B gel chromatography (Fig. 7c). The results show
that proteoglycans in the gradient from the GPN
treated postnuclear supernatant eluted in a major
peak at Kav V0.70, and a minor peak at Kav
V0.40. In the control fraction the major peak was
at Kav V0.40, while a minor peak was found at Kav
V0.70. Since proteoglycans from control lysosomal
fractions are eluted in one peak at Kav V0.70 (not
shown, but see Fig. 3b), the peak found at V1.17
g/ml in the density gradient from GPN treated post-
nuclear supernatants represents both degradation
products from the density shifted lysosomes as well
as intact material in endosomes/prelysosomes.
4. Discussion
In this study we have characterized the internal-
ization and degradation of membrane anchored HS
proteoglycans in cultured rat hepatocytes. By subcel-
lular fractionation in Nycodenz gradients we were
able to identify low density organelles participating
in transport of proteoglycans from the trans-Golgi
network to the plasma membrane. This transport is
fast and in the order of minutes. This is in agreement
with other reports [34^36]. Since no HS proteogly-
cans were found in lysosomes at early time points
after a pulsing with [35S]sulfate, HS proteoglycans
in rat hepatocytes are transported from the trans-
Golgi network exclusively to the plasma membrane,
and not directly to endosomal/lysosomal compart-
ments.
We estimated the half-life of HS proteoglycans in
cultured hepatocytes to be V2^3 h. The half-life of
HS proteoglycans found at the plasma membrane or
in recycling compartments was also estimated to be
2^3 h, indicating that the intracellular degradation is
a relatively fast process. This turnover rate is faster
than previously demonstrated by Oldberg et al. in
cultured rat hepatocytes (T1=2 V5^6 h) [14] and by
Yanagashita and Hascall in rat ovarian granulosa
cells (T1=2 V6 h) [34]. Nevertheless, the half-life of
HS proteoglycans at the cell surface is still much
longer than the half-life for plasma membrane com-
ponents in general. It has been shown that cultured
hepatocytes endocytose a membrane area equivalent
to 5^20 times the total cell surface area every hour
[37]. HS proteoglycans are therefore either actively
retained at the cell surface or they are internalized,
but to a large extent recycled back to the plasma
membrane. Recycling of HS proteoglycans has been
demonstrated in other cell types [38]. We found that
even at short incubations with [35S]sulfate (10 min
pulse followed by 15 min chase), only V50% of
HS proteoglycans were pronase sensitive. These re-
sults strongly indicate that a relatively large propor-
tion of the proteoglycans is continuously associated
with intracellular recycling compartments.
The nature of the labeled macromolecules corre-
sponds to HS proteoglycans. However, the Kav for
the intact HS proteoglycans was found to di¡er from
what has been described earlier for HS proteoglycans
in rat hepatocytes by other groups [18,28,30]. This
discrepancy could either be due to small variations
in conditions by which gel chromatography was per-
formed, or it could re£ect variances in HS proteogly-
can expression, both between di¡erent strains of rats,
and in cells in vivo and in cultures.
In addition to intact HS proteoglycans, we de-
tected small HS fragments (V7 kDa) with no protein
covalently attached. In pulse chase experiments,
these fragments were not present early in the chase
period, but were found in lysosomes, and to a lesser
extent in endosomes, at later time points. They
should, accordingly, represent degradation products
of the major HS proteoglycans described above. No
full length GAG chains were detected released from
protein, only cleaved GAG chains of approximately
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half of full size. This indicates that GAG chains are
cleaved soon after release from the protein core.
By use of several inhibitors we have characterized
the early phase of the degradation pathway. Labeled
proteoglycans were retained in early endosomes in
cells incubated at 19‡C or in the presence of the
microtubule inhibitor vinblastine. The size of the
proteoglycans after 3 h retention in these organelles
under these conditions was identical to that of intact
molecules. These results demonstrate that no degra-
dation of proteoglycans takes place in early endo-
somes. This is di¡erent from what has been observed
in rat ovarian granulosa cells [17]. In these cells, deg-
radation of the core protein and partial degradation
of the released HS chains takes place in the presence
of lysosomotropic agents, suggesting that it occurs in
an environment with almost neutral pH, such as
early endosomes [34,39]. A HS-degrading endoglyco-
sidase in rat liver plasma membranes has been de-
scribed [40]. It has been suggested that this enzyme
may be activated after co-internalization together
with HS proteoglycans in a primary endosome.
This hypothesis is not supported by our ¢ndings.
We conclude that no degradation of HS proteogly-
cans takes place in early endosomes. Either early
endosomes in rat hepatocytes do not contain the en-
zymes necessary for degradation of HS proteogly-
cans or these enzymes remain inactive. Prelysosomal
degradation of other proteins has been described in
rat hepatocytes [41]. However, a substantial part of
HS proteoglycans resides in a pronase resistant com-
partment, probably because they recycle between the
plasma membrane and an intracellular compartment.
Since recycling of plasma membrane components is
likely to take place via early endosomes, one would,
from a ‘metabolic’ point of view, not expect long
lived plasma membrane components to be degraded
in this compartment.
Experiments using the vacuolar ATPase inhibitor
ba¢lomycin A1 clearly showed that degradation of
HS proteoglycans in rat hepatocytes is a pH depen-
dent process. We could not detect degradation prod-
ucts when ba¢lomycin A1 was present. In addition to
raising the pH in the vacuolar system, ba¢lomycin
A1 blocks transport from endosomes to lysosomes
[42], possibly by inhibiting the budding of carrier
vesicle from early endosomes [43]. The e¡ects of ba-
¢lomycin A1 on degradation of HS proteoglycans in
hepatocytes could therefore be explained by two dif-
ferent mechanisms. Since treatment with ba¢lomycin
A1 also leads to accumulation of asialoorosomucoid
in endosomes in hepatocytes (Kjeken, unpublished
observations), we favor inhibition of intracellular
transport as the major mechanism by which ba¢lo-
mycin A1 exerts its e¡ect. Whether the HS proteo-
glycans are retained in early or late endosomes re-
mains to be elucidated. From our experiments,
however, the possibility that the HS proteoglycans
found in ba¢lomycin A1 treated cells are associated
with lysosomes could not be ruled out, as the density
distribution of the lysosomal marker enzyme, L-
AGA, in these cells was shifted towards 1.16 g/ml.
A possible explanation of the shift in density may be
that the lysosomes become lighter as endocytosed
material is retained in upstream endocytic compart-
ments.
We found that leupeptin interfered with two sepa-
rate steps in the degradation of HS proteoglycans:
(1) proteolytic degradation of the core protein, and
(2) the complete degradation of the single 7 kDa HS
oligosaccharide. The ¢rst step is compatible with the
inhibition of thiol sensitive proteases, which are re-
sponsible for degradation of the core protein.
Although inhibition was not complete, degradation
of core proteins was markedly retarded. This led to
accumulation of oligosaccharide chains with peptide
stubs of various sizes attached (Fig. 5h). Since such
intermediates could not be detected in control cells,
this degradation step is normally very rapid. Further-
more, accumulation of intermediate size degradation
products indicates that degradation of the core pro-
tein precedes the endoglycosidic degradation of HS
chains, and that this step may be a prerequisite for
intracellular endoglycosidic degradation to occur.
Since HS fragments remain inaccessible to the lyso-
somal enzymes necessary for the ¢nal degradation of
these molecules, these results can be explained by: (1)
the compartment in which HS chains are retained
and the compartment which contains enzymes neces-
sary for their ¢nal depolymerization are functionally
separate, and (2) inhibition of degradation by leu-
peptin somehow blocks transport between organelles
in the degradative pathway, or (3) both degradation
steps may take place within the same compartment,
but need to occur in a speci¢c sequential order, to
avoid steric hindrance created by the attached pep-
BBAMCR 14785 7-12-01
M. Egeberg et al. / Biochimica et Biophysica Acta 1541 (2001) 135^149 147
tides on the HS fragments. It has been shown pre-
viously that transport from late endosomes to lyso-
somes [44], and transport from endosomal carrier
vesicles to prelysosomal compartments [45], are in-
hibited by leupeptin. It has been speculated whether
this may be because: (a) undegraded molecules in the
upstream organelle lead to release of a factor(s) into
the cytosol, which blocks tra⁄cking between the or-
ganelles; (b) fusion between organelles, or between
organelles and vesicles, is dependent on a fusion-ac-
tive transmembrane protein that may be activated on
its cytosolic side after degradation at the luminal side
[45] ; (c) accumulation of undegraded substrates in
the downstream organelle acts by negative feedback
to reduce further uptake of substrates [44].
Leupeptin has similar e¡ects on HS proteoglycan
degradation in rat ovarian granulosa cells [46]. In
these cells (it was speculated that) treatment with
leupeptin led to retention of degradation intermedi-
ates with partially degraded core proteins bound to
intact HS chains in a prelysosomal compartment.
This conclusion was, however, based on studies of
the degradation pattern of the HS proteoglycans,
and no attempt to separate intracellular compart-
ments involved, was made.
We did not observe reduced transport of HS pro-
teoglycans to lysosomes in the presence of leupeptin
in rat hepatocytes. Although it may be speculated
whether one of the mechanisms, described above,
may interrupt transport between functionally di¡er-
ent lysosomal compartments which are not resolved
by our cell fractionation technique, we still favor the
more simplistic explanation, that both degradation
steps take place in the same lysosomal compartment,
but that the ¢nal degradation is dependent on the
protein core to be degraded ¢rst.
In conclusion, we ¢nd that HS proteoglycans in
cultured rat hepatocytes spend most of their lifetime
at the cell surface or in recycling compartments, be-
fore they are transported towards degradative com-
partments. No degradation takes place in early endo-
somes. The degradation process is rapid, and a 7 kDa
HS oligosaccharide is the only detectable intermedi-
ate. Although the degradation is mostly occurring in
lysosomal compartments, some degradation also
takes place in a late endosomal compartment, gener-
ating the same 7 kDa intermediate. The ¢nal degra-
dation of the 7 kDa HS oligosaccharide occurs in a
lysosomal compartment which contains endoglycosi-
dase activity.
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